Abstract:Immunotherapy has achieved efficacy for advanced colorectal cancer (CRC) patients with a mismatch-repair-deficient (dMMR) subtype. However, little immunotherapy efficacy was observed in patients with the mismatch repair-proficient (pMMR) subtype, and hence, identifying new immune therapeutic targets is imperative for those patients. In this study, transcriptome data of stage III/IV CRC patients were retrieved from the Gene Expression Omnibus database. The CIBERSORT algorithm was used to quantify immune cellular compositions, and the results revealed that M2 macrophage fractions were higher in pMMR patients as compared with those with the dMMR subtype; moreover, pMMR patients with higher M2 macrophage fractions experienced shorter overall survival (OS). Subsequently, weighted gene co-expression network analysis and protein–protein interaction network analysis identified six hub genes related to M2 macrophage infiltrations in pMMR CRC patients: CALD1 , COL6A1 , COL1A2 , TIMP3 , DCN , and SPARC . Univariate and multivariate Cox regression analyses then determined CALD1 as the independent prognostic biomarker for OS. CALD1 was upregulated specifically the in CMS4 CRC subtype, and single-sample Gene Set Enrichment Analysis (ssGSEA) revealed that CALD1 was significantly correlated with angiogenesis and TGF-β signaling gene sets enrichment scores in stage III/IV pMMR CRC samples. The Estimation of STromal and Immune cells in MAlignant Tumor tissues using Expression data (ESTIMATE) algorithm and correlation analysis revealed that CALD1 was significantly associated with multiple immune and stromal components in a tumor microenvironment. In addition, GSEA demonstrated that high expression of CALD1 was significantly correlated with antigen processing and presentation, chemokine signaling, leukocyte transendothelial migration, vascular smooth muscle contraction, cytokine–cytokine receptor interaction, cell adhesion molecules, focal adhesion, MAPK, and TGF-beta signaling pathways. Furthermore, the proliferation, invasion, and migration abilities of cancer cells were suppressed after reducing CALD1 expression in CRC cell lines. Taken together, multiple bioinformatics analyses and cell-level assays demonstrated that CALD1 could serve as a prognostic biomarker and a prospective therapeutic target for stage III/IV pMMR CRCs.

High MICAL-L2 expression and its role in the prognosis of colon adenocarcinoma

MICAL2 implies immunosuppressive features and acts as an independent and adverse prognostic biomarker in pancreatic cancer

MICAL2 is a Novel Nucleocytoplasmic Shuttling Protein Promoting Cancer Invasion and Growth of Lung Adenocarcinoma.

Prognostic biomarker MICAL2 and associates with proliferation, migration and immune infiltration in pancreatic adenocarcinoma

Identification Of Differentially Expressed Genes Between Mucinous Adenocarcinoma And Other Adenocarcinoma Of Colorectal Cancer Using Bioinformatics Analysis

Elucidating the role of MICAL1 in pan-cancer using integrated bioinformatics and experimental approaches

Molecular Profile Reveals Immune-Associated Markers of Lymphatic Invasion in Human Colon Adenocarcinoma.

Membrane Palmitoylated Protein 2 Serves as a Potential Biomarker for Colon Adenocarcinoma through Promoting CGAS-STING Pathway

MICAL2 Mediates P53 Ubiquitin Degradation Through Oxidating P53 Methionine 40 and 160 and Promotes Colorectal Cancer Malignance

MICAL-L2 is Essential for C-Myc Deubiquitination and Stability in Non-small Cell Lung Cancer Cells.

MICAL-L2, as an estrogen-responsive gene, is involved in ER-positive breast cancer cell progression and tamoxifen sensitivity via the Akt/mTOR pathway

MICAL1 Promotes the Proliferation in Acute Myeloid Leukemia and is Associated with Clinical Prognosis and Immune Infiltration

Characterization of the m6A-related lncRNA signature in predicting prognosis and immune response in patients with colon cancer

In-Silico Multi-Omics Analysis of the Functional Significance of Calmodulin 1 in Multiple Cancers

Bioinformatics and Experimental Approach Identify Lipocalin 2 As a Diagnostic and Prognostic Indicator for Lung Adenocarcinoma

MICAL2 Promotes Proliferation and Migration of Glioblastoma Cells Through TGF-β/p-Smad2/EMT-Like Signaling Pathway

Clinical M2 Macrophage-Related Genes Can Serve as a Reliable Predictor of Lung Adenocarcinoma

MICAL2 Is a Super Enhancer Associated Gene that Promotes Pancreatic Cancer Growth and Metastasis

Weighted Gene Co-expression Network Analysis Identifies CALD1 as a Biomarker Related to M2 Macrophages Infiltration in Stage III and IV Mismatch Repair-Proficient Colorectal Carcinoma

An Integrated Bioinformatic Investigation of Mitochondrial Energy Metabolism Genes in Colon Adenocarcinoma Followed by Preliminary Validation of CPT2 in Tumor Immune Infiltration

Gene Expression and Methylation Profiles Identified CXCL3 and CXCL8 As Key Genes for Diagnosis and Prognosis of Colon Adenocarcinoma.